APA (7th ed.) Citation

E, E., MO, K., AM, B., AA, M., AA, E., E, H., . . . H, Z. (2026). Correction to: Repurposing doxycycline as an adjunct to sitagliptin in type 2 diabetes mellitus: a randomized controlled study on glycemic, inflammatory, and cardiometabolic outcomes. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05640-y

Chicago Style (17th ed.) Citation

E, El-Khateeb, et al. "Correction to: Repurposing Doxycycline as an Adjunct to Sitagliptin in Type 2 Diabetes Mellitus: A Randomized Controlled Study on Glycemic, Inflammatory, and Cardiometabolic Outcomes." Naunyn-Schmiedeberg's Archives of Pharmacology 2026. https://doi.org/10.1007/s00210-026-05640-y.

MLA (9th ed.) Citation

E, El-Khateeb, et al. "Correction to: Repurposing Doxycycline as an Adjunct to Sitagliptin in Type 2 Diabetes Mellitus: A Randomized Controlled Study on Glycemic, Inflammatory, and Cardiometabolic Outcomes." Naunyn-Schmiedeberg's Archives of Pharmacology, 2026, https://doi.org/10.1007/s00210-026-05640-y.